CA 19-9 |
|
Test Code |
572 |
Unit |
U/ml |
Station |
Chemistry |
Synonym Name/Abbreviation |
CA 19-9 |
CPT Code |
86300 |
Performing Facility |
American Medical Labs, Herzliya |
Analyzer |
Roche cobas 6000 |
Test Method |
Electrochemiluminescence immunoassay (ECLIA) |
AML Preferred Tube |
5 mL SST gel |
Storage Instructions |
Refrigerated. Stability: 30 days 2 to 8 oC 3 months at -20oC ,Freeze only once. |
Min. Volume |
1 mL |
Turn-Around-Time |
One day |
Intended Use |
Immunoassay for the in vitro quantitative determination of CA 19‑9 in serum and human plasma. CA 19‑9 assay values can assist in the differential diagnosis and monitoring of .patients with pancreatic carcinoma |
Limitations |
Samples should not be taken from patients receiving therapy with high biotin doses (i.e. > 5 mg/day) until at least 8 hours following the last biotin administration. |
Patient Preparation |
No patient preparation needed. |
Reasons for Rejection |
Do not use sodium citrate tube, Improper labeling |
Adult Reference Ranges |
0 – 37 U/mL |